- Home
- ABBV vs DE Comparison
ABBV vs DE Comparison
Compare ABBV & DE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABBV | DE |
|---|---|---|
| Founded | 2012 | 1837 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.5B | 155.9B |
| IPO Year | 2012 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ABBV | DE |
|---|---|---|
| Price | $265.89 | $631.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 18 |
| Target Price | $253.71 | ★ $632.56 |
| AVG Volume (30 Days) | ★ 3.7M | 1.2M |
| Earning Date | 04-29-2026 | 05-21-2026 |
| Dividend Yield | ★ 3.39% | 1.16% |
| EPS Growth | ★ N/A | N/A |
| EPS | 2.42 | ★ 8.97 |
| Revenue | ★ $61,160,000,000.00 | $45,684,000,000.00 |
| Revenue This Year | $11.87 | N/A |
| Revenue Next Year | $8.12 | $9.39 |
| P/E Ratio | $109.32 | ★ $72.31 |
| Revenue Growth | ★ 8.57 | N/A |
| 52 Week Low | $190.75 | $433.00 |
| 52 Week High | $267.47 | $674.19 |
Technical Indicators
Market Signals| Indicator | ABBV | DE |
|---|---|---|
| Relative Strength Index (RSI) | 64.27 | 60.30 |
| Support Level | $218.78 | $556.03 |
| Resistance Level | $267.47 | $674.19 |
| Average True Range (ATR) | 5.08 | 18.66 |
| MACD | 1.38 | 3.67 |
| Stochastic Oscillator | 94.43 | 78.25 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About DE Deere & Company
Deere is the world's leading manufacturer of agricultural equipment and a major producer of construction machinery. The company is divided into four reporting segments: production & precision agriculture, or PPA, small agriculture & turf, or SAT, construction & forestry, or CF, and financial services, or FS, its captive finance subsidiary. The core PPA business is the largest contributor to sales and profits by far. Geographically, Deere sales are 60% US/Canada, 17% Europe, 14% Latin America, and 9% rest of the world. Deere goes to market through a robust dealer network that includes over 2,000 dealer locations in North America with reach into over 100 countries. John Deere Financial provides retail financing for machinery to its customers and wholesale financing for dealers.